Hausa
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Wang Liang

Lakabi: Babban Likita
Matsayi: Shugaban Sashe
Bayanin Mutum: Babban Likita, Farfesa, Mai Kula da Ph.D., a halin yanzu Daraktan Sashen Kula da Jini na Asibitin Peking Tongren. Ya kammala karatunsa daga Kwalejin Kiwon Lafiya ta Peking Union a shekarar 2010, inda ya yi karatun likitanci na tsawon shekaru takwas, kuma ya sami digirin Doctor of Medicine. Ya shafe sama da shekaru 10 yana bincike da kuma magance ciwon daji na jini (lymphoma, multiple myeloma, da sauransu), kuma yana da kwarewa mai zurfi a fannin bincike da kuma magance nau'ikan lymphomas da myeloma daban-daban, kuma ya ƙware a fannin rigakafi, chemotherapy, maganin ƙwayoyin CAR-T, dashen ƙwayoyin halitta na jini, da kuma jagorantar ci gaban bincike da magani na fannoni daban-daban (MDT). Babban abin da yake sha'awa a fannin bincike shi ne rigakafi da kuma binciken hanyoyin da za a bi wajen magance cutar lymphoma, kuma ya jagoranci wasu daga cikin Gidauniyar Kimiyyar Halitta ta Kasa ta China. Ya buga takardu sama da 40 na ƙwararru, ciki har da takardu sama da 30 da aka yi wa alama ta SCI, waɗanda aka buga a cikin Lancet Hematology, Journal of Hematology & Oncology, Leukemia, Clinical Cancer Research, Cancer Treatment Reviews, Cancer Therapy Reviews, da sauran mujallu da mujallu. Ya buga a cikin Lancet Hematology, Journal of Hematology & Oncology, Leukemia, Clinical Cancer Research, Cancer Treatment Reviews, Cancer, British Journal of Cancer, Annals of Hematology, da Leukemia & Lymphoma. Shi ne babban editan Standard Leukemia Diagnosis and Treatment, Standard Multiple Myeloma Diagnosis and Treatment, da Medical Oncology. An ba shi kyautar "Girmama Rayuwa-2017 Girmamawa ga Masu Warkarwa-Kyauta ta Matasa", kyautar "Tongren Elite" a shekarar 2020, kyautar "Mai Kyauwa ga Matasan Asibiti na Tongren" a shekarar 2020, da kuma kyautar farko ta "Mai Kyauwa ga Matasan Asibiti na Tongren" a shekarar 2020. Mai Kyauwa ga Matasan Asibiti na Tongren" a shekarar 2020, 'Mai Kyauwa ga Matasan Asibiti na '35 Masu Ciwon Kanjamau a Kasa da Shekaru 35 tare da Mafi Kyawun Iko a China'. Ƙungiyar Ilimi: Matashi Memba na Reshen Hematology na Ƙungiyar Likitoci ta China; Memba na dindindin na Kwamitin Lymphoma Immunotherapy na Ƙungiyar Rigakafin da Kula da Ciwon Kanjama ta Beijing; Memba na dindindin na Kwamitin Myeloma na Ƙungiyar Ilimi ta Likitoci ta China; Ƙwararren Gidauniyar Kimiyyar Halitta ta Ƙasa ta China. Shi ne editan mataimaki na Aging Pathobiology and Therapeutics, memba na kwamitin edita na Jaridar Rigakafin da Kula da Ciwon Kanjama ta China, matashi memba na kwamitin edita na Concord Medical Journal, kuma mai bita na Jaridar Hematology & Oncology da Cancer Biology & Medicine.

Wang Liang